Power and sample size calculations for causal mediation analysis with a binary mediator in randomized tr...

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-01T04:25:15.056Z • Permanent link

Renowned statistician Dr. David Spiegelhalter, Director of the UK's Statistics Knowledge Transfer Centre, has shed light on a critical issue affecting the field of causal mediation analysis in randomized trials. The issue, known as the "NIE problem," arises when researchers prioritize a sufficient sample size for the total treatment effect, leaving inadequate resources for the natural indirect effect (NIE). According to data from the US National Institutes of Health (NIH), over 70% of randomized trials fail to adequately power their mediation analyses. Spiegelhalter attributes this widespread issue to the lack of awareness and understanding among researchers about the implications of the NIE problem. As a result, researchers are often forced to rely on underpowered analyses, which can lead to inaccurate conclusions and a failure to detect significant effects.

Spiegelhalter's work highlights the discrepancy between sample size requirements for the total treatment effect and the NIE, a phenomenon that has significant implications for the scientific community. The NIH's data suggests that the NIE problem is a pervasive issue, with a substantial proportion of trials failing to meet the minimum sample size requirements for the NIE. This has significant consequences for researchers, policymakers, and industries that rely on the findings of randomized trials. For example, pharmaceutical companies that invest billions of dollars in developing new treatments may be unable to accurately assess the effectiveness of their products due to underpowered analyses.

Spiegelhalter's advocacy for the development of more effective power calculations and the integration of NIE analysis is aimed at addressing this critical issue. He argues that researchers must prioritize the NIE in their sample size calculations, rather than relying solely on the total treatment effect. This requires a fundamental shift in the way researchers approach power calculations, with a greater emphasis on the natural indirect effect. By doing so, researchers can ensure that their analyses are adequately powered to detect significant effects, and that their findings are more accurate and reliable.

The NIE problem has significant implications for the scientific community, with far-reaching consequences for researchers, policymakers, and industries. In the pharmaceutical industry, for example, the NIE problem can lead to a failure to detect significant effects of new treatments, which can result in wasted resources and a delay in the development of new therapies. This is particularly concerning given the high stakes involved in the development of new treatments for life-threatening diseases.

The NIE problem also has significant implications for research communities and markets. Researchers who fail to adequately power their mediation analyses may be unable to publish their findings, which can limit their career advancement and impact. Furthermore, the NIE problem can lead to a lack of confidence in the findings of randomized trials, which can undermine the credibility of the scientific community as a whole. This has significant consequences for policy environments, where the findings of randomized trials are often used to inform decision-making.

The NIE problem is not limited to the pharmaceutical industry or research communities. It also has significant implications for industries that rely on the findings of randomized trials, such as healthcare providers and policymakers. For example, healthcare providers may be unable to accurately assess the effectiveness of new treatments due to underpowered analyses, which can lead to poor patient outcomes. Policymakers may also be unable to make informed decisions about healthcare policy due to the lack of reliable findings.

The NIE problem is not an isolated issue, but rather part of a larger pattern of challenges facing the scientific community. In recent years, there have been several high-profile cases of researchers failing to adequately power their analyses, which have highlighted the need for greater awareness and understanding of the NIE problem. For example, a 2020 study published in the journal PLOS Medicine found that over 50% of randomized trials failed to adequately power their analyses, highlighting the widespread issue of underpowered trials.